RNase L mediated protection from virus induced demyelination.
about
Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1New insights into the role of RNase L in innate immunityThe Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate ResponseCoronavirus gene 7 counteracts host defenses and modulates virus virulencePKR mediated regulation of inflammation and IL-10 during viral encephalomyelitis.IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination.Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis.Intracellular immunity: finding the enemy within--how cells recognize and respond to intracellular pathogensEnterovirus infections of the central nervous system.Factors supporting intrathecal humoral responses following viral encephalomyelitis.Analysis of the host transcriptome from demyelinating spinal cord of murine coronavirus-infected mice.Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis.MMP9 deficiency does not decrease blood-brain barrier disruption, but increases astrocyte MMP3 expression during viral encephalomyelitis.CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitisMyd88 Initiates Early Innate Immune Responses and Promotes CD4 T Cells during Coronavirus Encephalomyelitis.Oligodendroglia are limited in type I interferon induction and responsiveness in vivoEnhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis.Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis.CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitis.Cell-type-specific activation of the oligoadenylate synthetase-RNase L pathway by a murine coronavirus.IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis.Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/beta interferon induction in macrophages.RNase L Suppresses Androgen Receptor Signaling, Cell Migration and Matrix Metalloproteinase Activity in Prostate Cancer Cells.Viruses and the cellular RNA decay machinery.Interferon-stimulated genes: roles in viral pathogenesis.Rapid RNase L-Driven Arrest of Protein Synthesis in the dsRNA Response without Degradation of Translation Machinery.Enzymatic Pre-treatment of Wastewater to Minimize Recovery by Reverse Transcriptase PCR of RNA from Inactive Bacteriophages.Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology.
P2860
Q24309199-401AC4FA-B528-44AD-9565-99054D63A575Q24597466-6C48852E-A460-47D6-AFFF-54A568648D25Q26772138-AB5AA457-667E-4680-ACA5-30A3B6534AD0Q27349527-38C89FDC-49C0-4549-9060-63599402FED3Q33606456-C9F31354-588E-428E-B591-308C76211079Q33795818-79357D61-4F1C-4C69-829A-BDF635F3274AQ34059107-2F229C6F-51F6-4E99-A9C2-8358C31F714CQ34319249-6F9E7680-74BB-4B74-9E6D-87845D9F5A0DQ34697319-8F3BDBF4-6A93-4A2E-A512-188A6CAF446FQ34742821-E209ED4C-2543-478D-BACC-05AEA3C74109Q34995049-B5E6A499-F0CB-44CF-AC4F-51489BCAE99EQ35176347-EC160012-0A05-4A10-8C34-25EC1E640A4DQ35216111-A761BA1A-A8ED-4F9B-8891-7F5DAA622802Q35826089-B000E596-F666-414C-BC57-81BD9D081996Q35973650-72D02945-41C6-40E3-81A3-69449BA47792Q36173898-EE6FDEC0-1104-4733-BC94-62C936AA8D65Q36535632-443C5C6D-06E5-4182-BA2B-C1124DBCB3F7Q36667911-5241D66E-F5DA-4BC8-8FF5-23B1DAE0A4EFQ36788638-7DB481F0-0728-486C-9B68-86B7D6E266A1Q37036782-F125379B-630D-4FAB-83C4-9BBA7E340804Q37228165-2E2140E5-60A4-43A5-9482-0DBCFE8B5978Q37547551-3B57AD09-7389-458D-AD5F-CFF22CAF2A01Q37729091-8E164593-0F6E-4146-94A2-B76513657C0DQ37940382-4EAB7638-D941-4898-AB7F-A03319FA3718Q38203069-24AC2669-4226-4D53-829E-9F80D787AF0CQ38624988-DA587096-4D5E-4565-A80C-7DA5820426E1Q42144865-D3FE0884-EEC0-4EE3-955D-2ECC18821B0BQ42165997-CD971293-8375-4CEC-B848-9AE555334BB7
P2860
RNase L mediated protection from virus induced demyelination.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
RNase L mediated protection from virus induced demyelination.
@ast
RNase L mediated protection from virus induced demyelination.
@en
type
label
RNase L mediated protection from virus induced demyelination.
@ast
RNase L mediated protection from virus induced demyelination.
@en
prefLabel
RNase L mediated protection from virus induced demyelination.
@ast
RNase L mediated protection from virus induced demyelination.
@en
P2093
P2860
P1433
P1476
RNase L mediated protection from virus induced demyelination.
@en
P2093
Cornelia C Bergmann
David R Hinton
Derek D C Ireland
Parul Kapil
Roscoe A Atkinson
Stephen A Stohlman
P2860
P304
P356
10.1371/JOURNAL.PPAT.1000602
P577
2009-10-02T00:00:00Z